This is unpublished
Stock photo of an ambulance
News

UW researchers develop innovative solution for prehospital hemorrhagic shock care

July 12, 2024
News Spotlight Image 3
Suzie H. Pun
News Spotlight Image 2
Dr. Alex St. John
Dr. White
Pinned
Back to top

A promising development at the University of Washington could help those experiencing extensive blood loss after a traumatic injury. 

Dr. Nathan White and Suzie H. Pun led the team comprised of several UW researchers, including emergency medicine's Dr. Alex St. John, Senior Research Scientist Xu Wang, Research Scientist Kristyn Ringgold, and Research Study Coordinator Sarah Stucky.

Their research, recently published in the journal Angewandte Chemie, details how a novel star-shaped polymer solution could mitigate the effects of severe hemorrhagic shock. This approach could greatly enhance preclinical treatment in time-critical and resource-limited emergency scenarios.

According to the team, there are few options available right now for damage control resuscitation (DCR) of trauma victims. Due to this, they designed injectable polymers for use as low-volume resuscitants (LVRs). Using RAFT polymerization, they evaluated the effect of polymer size, architecture, and chemical composition upon both blood coagulation and resuscitation in a rat hemorrhagic shock model.

Traumatic injury is a leading cause of global suffering and death. We rationally design polymeric, low volume resuscitants (LVRs) for the prehospital treatment of severe hemorrhagic shock. By varying polymer architecture, Rg, and composition to influence resuscitation, coagulation, and biodistribution, we developed a radiant star polymer that is non-coagulopathic and corrects 60 % total blood volume (TBV) loss when given at only 10 % TBV. This highly portable LVR has profound potential for application in trauma medicine.

A star-shaped polymer emerged as an effective LVR that doesn't affect blood clotting. In rat models, administering 10% of this polymer solution after a 60% blood loss restored blood pressure and overcame shock without adverse effects on clotting or organs. High doses of polymer produced no observable adverse effects on blood clotting or organs, making this an improvement over colloidal resuscitants currently in development.

The team's research was recently highlighted by the journal. Read more about their findings here.

News Categories

Recent News

Stock photo of an ambulance
10 hours 30 minutes ago
UW researchers develop innovative solution for prehospital h…
Dr. White
Dr. Alex St. John
Suzie H. Pun
WA-CEP Logo
1 month ago
Dr. Lu receives 2024 WA-ACEP Wellness Award
Dr. Dave Lu
Stock photo of buprenorphine treatment bottle
1 month ago
New treatment resources rolled out as opioid overdoses incre…
Dr. Chris Buresh Headshot